FIP1L1-PDGFRA Detection Kit
£735.00
The FIP1L1-PDGFRA Detection Kit employs one-step RT-qPCR technology for the rapid, accurate detection of the FIP1L1-PDGFRA fusion gene, which is associated with certain types of leukemia, including chronic eosinophilic leukemia and a subset of acute myeloid leukemia (AML). Offering superior analytical sensitivity (log4 reduction) and accurate relative quantitation through multiplex PCR, this CE-IVD certified kit is compatible with FAM and VIC/HEX dual-color real-time PCR instruments, making it a vital tool for the diagnosis and management of leukemia.
The FIP1L1-PDGFRA Detection Kit employs one-step RT-qPCR technology for the rapid, accurate detection of the FIP1L1-PDGFRA fusion gene, which is associated with certain types of leukemia, including chronic eosinophilic leukemia and a subset of acute myeloid leukemia (AML). Offering superior analytical sensitivity (log4 reduction) and accurate relative quantitation through multiplex PCR, this CE-IVD certified kit is compatible with FAM and VIC/HEX dual-color real-time PCR instruments, making it a vital tool for the diagnosis and management of leukemia.
- Superior Analytical Sensitivity: Achieves a log4 reduction in detection sensitivity, enabling the identification of low levels of the FIP1L1-PDGFRA fusion transcript.
- One-Step RT-qPCR Technology: Streamlines the testing process, making it both quick and straightforward to execute.
- Multiplex PCR: Facilitates accurate relative quantitation by comparing fusion transcripts against ABL1 gene expression, enhancing diagnostic precision.
- Instrument Compatibility: Designed for use with FAM and VIC/HEX dual-color real-time PCR instruments, ensuring versatility across laboratory settings.
- CE-IVD Certification: Meets European standards for in vitro diagnostic medical devices, ensuring the kit’s reliability and quality.
- Efficient Leukemia Diagnosis: Simplifies the detection of the FIP1L1-PDGFRA fusion gene, crucial for diagnosing and monitoring specific leukemia types.
- High Sensitivity and Accuracy: Ensures reliable detection and quantitation of the fusion gene, even at minimal levels, facilitating early diagnosis and intervention.
- Ease of Use: The one-step RT-qPCR method reduces the complexity and duration of the testing procedure, enabling routine diagnostic use.
- Leukemia Diagnosis and Monitoring: Specifically targets the FIP1L1-PDGFRA fusion gene for patients suspected of or diagnosed with chronic eosinophilic leukemia or a subset of acute myeloid leukemia (AML), playing a key role in diagnosis, prognosis, and treatment monitoring strategies.
- Technology: Utilizes one-step RT-qPCR with multiplex PCR for the detection and relative quantitation of the FIP1L1-PDGFRA fusion transcript.
- Sensitivity: Features superior analytical sensitivity (log4 reduction) for detecting low levels of the target gene.
- Compatibility: Compatible with FAM and VIC/HEX dual-color real-time PCR instruments.
- Certification: Carries the CE-IVD mark, indicating compliance with EU regulations for in vitro diagnostic use.
Why Choose Clent
We strive to enable our customers to focus on the results of their work, rather than the tools they use. Need to speak with a member of our team? Get in touch today.
